Further investigation of RBBP9 SH activity in hPSCs might also provide a useful framework for understanding a wide variety of human cancers in which RBBP9 is expressed—including pancreatic, ovary, colon, lung, and breast cancer [4]. Here, RBBP9 is linked to breast carcinoma.